Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout

AIMS : With the high prevalence of gout and associated cardiovascular (CV) diseases, information on the comparative CV safety of individual urate-lowering drugs becomes increasingly important. However, few studies examined the CV risk of uricosuric agents. We compared CV risk among patients with gou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Eun Ha, Park, Eun Hye, Shin, Anna, Song, Jung Soo, Kim, Seoyoung C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633759/
https://www.ncbi.nlm.nih.gov/pubmed/34508567
http://dx.doi.org/10.1093/eurheartj/ehab619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633759/
https://www.ncbi.nlm.nih.gov/pubmed/34508567
http://dx.doi.org/10.1093/eurheartj/ehab619

Ejemplares similares